Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors
Gespeichert in:
| Veröffentlicht in: | Kardiologia polska 2018-01, Vol.76 (3), p.670-670 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 670 |
|---|---|
| container_issue | 3 |
| container_start_page | 670 |
| container_title | Kardiologia polska |
| container_volume | 76 |
| creator | Szymański, Filip M Płatek, Anna E Dziadziuszko, Rafał Łęgosz, Paweł Palczewski, Piotr |
| description | |
| doi_str_mv | 10.5603/KP.2018.0061 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5603_KP_2018_0061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29558014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c291t-692bb4aabe1666fe59b6ff389d5a80b6d6d8096cdbe659b000c7075fa01d05173</originalsourceid><addsrcrecordid>eNo9kM9OwzAMhyMEYmNw44zyAHQ47Zo2RzTxT5vEDnCu3NTdAl06JRmoT8Er02qDiy3Ln3-yPsauBUxTCcndYjWNQeRTAClO2FjkKotmcaZO2RggjiMFSTxiF95_9GMuhThno1ilaQ5iNmY_c3SVab_Q632DjnusKXS8rbltv6jpq438FpuGa-pLs7drrtFqcry1ug0bcrjruLEc-Q6DIRt4cISBKv5twuYYsybbg8G01g_ZoXOtN5b4p7HoqT_fmNKE1vlLdlZj4-nq2Cfs_fHhbf4cLV-fXub3y0jHSoRIqrgsZ4glCSllTakqZV0nuapSzKGUlaxyUFJXJcl-BwA6gyytEUQFqciSCbs95Or-E--oLnbObNF1hYBi8FosVsXgtRi89vjNAd_tyy1V__CfyOQXoz921w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Szymański, Filip M ; Płatek, Anna E ; Dziadziuszko, Rafał ; Łęgosz, Paweł ; Palczewski, Piotr</creator><creatorcontrib>Szymański, Filip M ; Płatek, Anna E ; Dziadziuszko, Rafał ; Łęgosz, Paweł ; Palczewski, Piotr</creatorcontrib><identifier>ISSN: 0022-9032</identifier><identifier>EISSN: 1897-4279</identifier><identifier>DOI: 10.5603/KP.2018.0061</identifier><identifier>PMID: 29558014</identifier><language>eng</language><publisher>Poland</publisher><subject>Acrylamides ; Afatinib ; Aniline Compounds ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - secondary ; Cardiotonic Agents - therapeutic use ; Cardiovascular Diseases - chemically induced ; Cardiovascular Diseases - prevention & control ; Gefitinib ; Humans ; Lung Neoplasms - drug therapy ; Lung Neoplasms - pathology ; Middle Aged ; Nebivolol - therapeutic use ; Piperazines - adverse effects ; Piperazines - therapeutic use ; Protein Kinase Inhibitors - adverse effects ; Protein Kinase Inhibitors - therapeutic use ; Quinazolines - adverse effects ; Quinazolines - therapeutic use ; Ramipril - therapeutic use</subject><ispartof>Kardiologia polska, 2018-01, Vol.76 (3), p.670-670</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c291t-692bb4aabe1666fe59b6ff389d5a80b6d6d8096cdbe659b000c7075fa01d05173</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29558014$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szymański, Filip M</creatorcontrib><creatorcontrib>Płatek, Anna E</creatorcontrib><creatorcontrib>Dziadziuszko, Rafał</creatorcontrib><creatorcontrib>Łęgosz, Paweł</creatorcontrib><creatorcontrib>Palczewski, Piotr</creatorcontrib><title>Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors</title><title>Kardiologia polska</title><addtitle>Kardiol Pol</addtitle><subject>Acrylamides</subject><subject>Afatinib</subject><subject>Aniline Compounds</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - secondary</subject><subject>Cardiotonic Agents - therapeutic use</subject><subject>Cardiovascular Diseases - chemically induced</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Gefitinib</subject><subject>Humans</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - pathology</subject><subject>Middle Aged</subject><subject>Nebivolol - therapeutic use</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - therapeutic use</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Quinazolines - adverse effects</subject><subject>Quinazolines - therapeutic use</subject><subject>Ramipril - therapeutic use</subject><issn>0022-9032</issn><issn>1897-4279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM9OwzAMhyMEYmNw44zyAHQ47Zo2RzTxT5vEDnCu3NTdAl06JRmoT8Er02qDiy3Ln3-yPsauBUxTCcndYjWNQeRTAClO2FjkKotmcaZO2RggjiMFSTxiF95_9GMuhThno1ilaQ5iNmY_c3SVab_Q632DjnusKXS8rbltv6jpq438FpuGa-pLs7drrtFqcry1ug0bcrjruLEc-Q6DIRt4cISBKv5twuYYsybbg8G01g_ZoXOtN5b4p7HoqT_fmNKE1vlLdlZj4-nq2Cfs_fHhbf4cLV-fXub3y0jHSoRIqrgsZ4glCSllTakqZV0nuapSzKGUlaxyUFJXJcl-BwA6gyytEUQFqciSCbs95Or-E--oLnbObNF1hYBi8FosVsXgtRi89vjNAd_tyy1V__CfyOQXoz921w</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Szymański, Filip M</creator><creator>Płatek, Anna E</creator><creator>Dziadziuszko, Rafał</creator><creator>Łęgosz, Paweł</creator><creator>Palczewski, Piotr</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180101</creationdate><title>Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors</title><author>Szymański, Filip M ; Płatek, Anna E ; Dziadziuszko, Rafał ; Łęgosz, Paweł ; Palczewski, Piotr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c291t-692bb4aabe1666fe59b6ff389d5a80b6d6d8096cdbe659b000c7075fa01d05173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acrylamides</topic><topic>Afatinib</topic><topic>Aniline Compounds</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - secondary</topic><topic>Cardiotonic Agents - therapeutic use</topic><topic>Cardiovascular Diseases - chemically induced</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Gefitinib</topic><topic>Humans</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - pathology</topic><topic>Middle Aged</topic><topic>Nebivolol - therapeutic use</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - therapeutic use</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Quinazolines - adverse effects</topic><topic>Quinazolines - therapeutic use</topic><topic>Ramipril - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szymański, Filip M</creatorcontrib><creatorcontrib>Płatek, Anna E</creatorcontrib><creatorcontrib>Dziadziuszko, Rafał</creatorcontrib><creatorcontrib>Łęgosz, Paweł</creatorcontrib><creatorcontrib>Palczewski, Piotr</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Kardiologia polska</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szymański, Filip M</au><au>Płatek, Anna E</au><au>Dziadziuszko, Rafał</au><au>Łęgosz, Paweł</au><au>Palczewski, Piotr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors</atitle><jtitle>Kardiologia polska</jtitle><addtitle>Kardiol Pol</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>76</volume><issue>3</issue><spage>670</spage><epage>670</epage><pages>670-670</pages><issn>0022-9032</issn><eissn>1897-4279</eissn><cop>Poland</cop><pmid>29558014</pmid><doi>10.5603/KP.2018.0061</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-9032 |
| ispartof | Kardiologia polska, 2018-01, Vol.76 (3), p.670-670 |
| issn | 0022-9032 1897-4279 |
| language | eng |
| recordid | cdi_crossref_primary_10_5603_KP_2018_0061 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Acrylamides Afatinib Aniline Compounds Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - secondary Cardiotonic Agents - therapeutic use Cardiovascular Diseases - chemically induced Cardiovascular Diseases - prevention & control Gefitinib Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Middle Aged Nebivolol - therapeutic use Piperazines - adverse effects Piperazines - therapeutic use Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Quinazolines - adverse effects Quinazolines - therapeutic use Ramipril - therapeutic use |
| title | Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T04%3A23%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20safety%20of%20novel%20non-small%20cell%20lung%20cancer%20oncotherapy%20in%20a%20patient%20treated%20with%20novel%20generations%20of%20tyrosine%20kinase%20inhibitors&rft.jtitle=Kardiologia%20polska&rft.au=Szyma%C5%84ski,%20Filip%20M&rft.date=2018-01-01&rft.volume=76&rft.issue=3&rft.spage=670&rft.epage=670&rft.pages=670-670&rft.issn=0022-9032&rft.eissn=1897-4279&rft_id=info:doi/10.5603/KP.2018.0061&rft_dat=%3Cpubmed_cross%3E29558014%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29558014&rfr_iscdi=true |